Magnitude of risk of CHF by increments of cumulative anthracycline dose. Matching criteria for cases and controls included: age at HCT (±5 years), year of HCT (±2 years), and duration of follow-up. The model was also adjusted for sex, underlying diagnosis (lymphoma vs nonlymphoma), and pre-HCT exposure to chest radiation.